-

Lost Money on DaVita Inc. Shares? The Law Offices of Frank R. Cruz Investigates Potential Securities Fraud After 6.23% Stock Decline

Investigation centers on the October 20, 2026 news about DaVita Inc.; investors with losses may have potential claims to recover them

LOS ANGELES--(BUSINESS WIRE)--DaVita Inc. ("DaVita" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investigating potential securities fraud claims on behalf of investors in DaVita Inc. (NYSE: DVA), examining whether the Company may have violated the federal securities laws. The investigation centers on the disclosure about DaVita Inc. on October 20, 2026.

If you lost money on DaVita Inc. securities, share your DaVita Inc. loss information with the firm to learn about potentially pursuing a claim to recover your losses.

DaVita Inc. investigation at a glance

  • Date of disclosure: October 20, 2026
  • Share price decline: $11.65 per share, or 6.23%
  • Closing price: $175.35 on October 20, 2026

What happened?

On October 20, 2026, the U.S. Department of Health and Human Services (“HHS”) announced its Kidney Care National Plan. Among other things, the HHS stated the combined market share of the two largest dialysis chains, DaVita and Fresenius Medical Care, control approximately 74% of the market, and the HHS would be investigating potential anticompetitive payment and legal strategies used by the largest firms to garner larger reimbursements without providing superior patient care.

On this news, DaVita’s stock fell $11.65 or 6.23%, to close at $175.35 on October 20, 2026, thereby injuring investors.

"DaVita Inc. shares dropped 6.23% after it was disclosed on October 20, 2026 that the U.S. Department of Health and Human Services announced its Kidney Care National Plan, stating that DaVita and Fresenius Medical Care control approximately 74% of the dialysis market and that it would investigate potential anticompetitive payment and legal strategies used by the largest firms to obtain larger reimbursements. Our investigation will look at whether investors had complete and accurate information before that disclosure," said Frank R. Cruz of The Law Offices of Frank R. Cruz.

What should DaVita Inc. investors do now?

The Law Offices of Frank R. Cruz is investigating potential claims on behalf of DaVita Inc. investors. Investors who lost money can visit the DaVita Inc. investigation page, email info@frankcruzlaw.com, or call 310-914-5007.

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.

Questions and answers about the DaVita Inc. investigation

Who is eligible? Investors who purchased DaVita Inc. securities and suffered losses may have claims, and can contact the firm to find out whether the DaVita Inc. investigation affects them.

What does a securities fraud investigation involve? In the DaVita Inc. investigation, The Law Offices of Frank R. Cruz is examining whether the Company or its executives may have made false or misleading statements to investors in violation of the federal securities laws.

Is there a lawsuit? This release announces an investigation by The Law Offices of Frank R. Cruz, not a lawsuit. If a securities class action is later filed against DaVita Inc., investors may be able to seek appointment as lead plaintiff.

How are attorneys' fees handled? The Law Offices of Frank R. Cruz works on contingency, so DaVita Inc. investors pay no attorneys' fees up front. Any attorneys' fees and litigation expenses come only from a recovery, if there is one, and require court approval.

Information for whistleblowers

Anyone with non-public information about DaVita Inc. should consider their options to assist the investigation or participate in the SEC Whistleblower Program. The program allows whistleblowers who provide original information leading to a successful SEC enforcement action to receive awards of 10 to 30 percent of the sanctions collected, when those sanctions exceed $1 million. For more information, contact Frank R. Cruz at 310-914-5007 or email info@frankcruzlaw.com.

About The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz investigates and prosecutes securities fraud and corporate malfeasance class actions. With nearly 20 years of litigation experience, the firm focuses on complex securities class actions and gives each client personal, one-on-one attention throughout the legal process.

Prior results do not guarantee a similar outcome.

Related links

Follow The Law Offices of Frank R. Cruz for updates on Twitter: twitter.com/FRC_LAW

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Frank R. Cruz
The Law Offices of Frank R. Cruz
Los Angeles, CA
Email: fcruz@frankcruzlaw.com
Telephone: 310-914-5007
www.frankcruzlaw.com

The Law Offices of Frank R. Cruz

NYSE:DVA

Release Versions

Contacts

Frank R. Cruz
The Law Offices of Frank R. Cruz
Los Angeles, CA
Email: fcruz@frankcruzlaw.com
Telephone: 310-914-5007
www.frankcruzlaw.com

More News From The Law Offices of Frank R. Cruz

Securities Fraud Lawsuit Filed Against O-I Glass, Inc.: The Law Offices of Frank R. Cruz Outlines Lead Plaintiff Deadline

LOS ANGELES--(BUSINESS WIRE)--A securities class action lawsuit has been filed against O-I Glass, Inc. ("O-I Glass" or the "Company") (NYSE: OI) on behalf of investors who purchased or otherwise acquired O-I Glass, Inc. securities from March 14, 2025 to July 28, 2026, inclusive. The Law Offices of Frank R. Cruz today reported the case, Bryan v. O-I Glass, Inc. et al., filed on October 29, 2026 in the U.S. District Court Ohio Northern District Court (Case No. 3:26-cv-02849). Lead plaintiff motion...

Deadline Alert: Yiren Digital Ltd. Shareholders Have Until December 28, 2026 to Seek Lead Plaintiff Appointment in Securities Fraud Lawsuit, The Law Offices of Frank R. Cruz Notes

LOS ANGELES--(BUSINESS WIRE)--The deadline for Yiren Digital Ltd. ("Yiren" or the "Company") (NYSE: YRD) investors to seek appointment as lead plaintiff in a securities class action lawsuit is December 28, 2026. The lawsuit was filed on behalf of investors who purchased or otherwise acquired Yiren Digital Ltd. securities from April 29, 2026 to October 13, 2026, inclusive. The Law Offices of Frank R. Cruz today reminded investors of the deadline in the case, Lester et al v. Yiren Digital Ltd. et...

Securities Fraud Lawsuit Filed Against Tenax Therapeutics, Inc.: The Law Offices of Frank R. Cruz Outlines Lead Plaintiff Deadline

LOS ANGELES--(BUSINESS WIRE)--A securities class action lawsuit has been filed against Tenax Therapeutics, Inc. ("Tenax" or the "Company") (NASDAQ: TENX) on behalf of investors who purchased or otherwise acquired Tenax Therapeutics, Inc. securities from November 13, 2023 to August 7, 2026, inclusive. The Law Offices of Frank R. Cruz today reported the case, Katz v. Tenax Therapeutics, Inc. et al., filed on October 26, 2026 in the U.S. District Court North Carolina Middle District (Case No. 1:26-...
Back to Newsroom